China Pharma Outsourcing Annual Review 2010

In our 2009 China Pharma Outsourcing Annual Review, we analyzed and forecasted the possible development trends of the Chinese pharma outsourcing industry in 2010. After one year now, it has turned out that the market development of this Chinese industry has been well in line with our predictions.

Now that the industry has just entered a new year, many organizations and professionals around the world have started wondering again how this Chinese industry will be likely developing in 2011. Prompted by their interest in the Chinese industry as well as our obligation to best meet their demand, we performed a thorough and detailed review again about the development of this Chinese industry in 2010.

This Annual Review, published by JZMed, Inc, a world renowned market research firm specialized in Chinese pharmaceutical and biotechnology industries, will help readers gain a deep and clear insight into what have really happened to the Chinese industry in 2010, figure out a general development trend of the pharma outsourcing industry both in the world and in China, and better understand how the industry will likely move in 2011. In the end of the Review are included the detailed company profiles of ten China-based CROs/CMOs that were mentioned in the report.

The Review is a must-read book to global pharmaceutical and biotechnology companies that are seeking collaboration with Chinese companies, multinational outsourcing service providers that have plans to enter the Chinese market or further expand their current presence in China, venture capital investors interested in the investment opportunities in the Chinese pharmaceutical outsourcing industry, and market research/consultancy companies seeking the information of the Chinese pharma outsourcing industry.